Recombinant Human CEACAM-5/CD66e (145-322) Protein
Beta LifeScience
SKU/CAT #: BLK-00175P-100UG
Human CEACAM-5 (145-322) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human CEACAM-5/CD66e (145-322) Protein
Beta LifeScience
SKU/CAT #: BLK-00175P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CEACAM-5/CD66e (145-322) Protein is expressed from HEK293 with His tag at the C-terminus.; It contains Pro145-Pro322. |
Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
Accession | P06731 |
Target Symbol | CEACAM-5/CD66e (145-322) |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Pro145-Pro322 |
Mol. Weight | The protein has a predicted MW of 20.66 kDa. Due to glycosylation, the protein migrates to 50-70 kDa based on Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22 um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1 EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) was identified as a metastatic driver. CEACAM5 overproduction enriched for an epithelial gene expression pattern and facilitated tumor outgrowth at metastatic sites. Tissues from patients with metastatic breast cancer confirmed elevated levels of CEACAM5 in lung metastases relative to breast tumors, and an inverse correlation between CEACAM5 and the mesenchymal marker vimentin was demonstrated. |